VOYA Investment Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-45,575
Closed -$850K 2967
2022
Q1
$850K Sell
45,575
-268,564
-85% -$4.83M ﹤0.01% 1572
2021
Q4
$6.72M Sell
314,139
-9,422
-3% -$186K 0.01% 741
2021
Q3
$5.98M Sell
323,561
-69,947
-18% -$1.41M 0.01% 784
2021
Q2
$8.43M Sell
393,508
-69,173
-15% -$1.41M 0.02% 672
2021
Q1
$8.93M Buy
+462,681
New +$8.15M 0.02% 620

Other funds holding OCDX

VOYA Investment Management's OCDX Position: Q2 2022 in Review

VOYA Investment Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 45,575 shares — an estimated $850K sold.

VOYA Investment Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $8.93M in Q1 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • VOYA Investment Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 45,575 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $850K.
  • VOYA Investment Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • VOYA Investment Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $8.93M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.